IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 121 filers reported holding IRADIMED CORP in Q4 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $650,224 | -13.5% | 14,798 | -13.4% | 0.00% | 0.0% |
| Q1 2024 | $751,701 | +121.8% | 17,088 | +139.3% | 0.00% | – |
| Q4 2023 | $338,936 | -46.6% | 7,140 | -50.1% | 0.00% | -100.0% |
| Q3 2023 | $634,668 | +22.3% | 14,304 | +31.6% | 0.00% | 0.0% |
| Q2 2023 | $519,029 | +75.1% | 10,872 | +44.3% | 0.00% | – |
| Q1 2023 | $296,384 | +213.0% | 7,532 | +125.0% | 0.00% | – |
| Q4 2022 | $94,687 | -99.9% | 3,347 | -7.4% | 0.00% | – |
| Q3 2022 | $108,667,000 | +83.6% | 3,615 | +107.3% | 0.00% | – |
| Q2 2022 | $59,191,000 | -59.4% | 1,744 | -46.4% | 0.00% | – |
| Q1 2022 | $145,775,000 | +40.1% | 3,251 | +44.4% | 0.00% | – |
| Q4 2021 | $104,065,000 | +182.9% | 2,252 | +105.7% | 0.00% | – |
| Q3 2021 | $36,781,000 | +199.2% | 1,095 | +162.0% | 0.00% | – |
| Q2 2021 | $12,293,000 | -35.4% | 418 | -43.4% | 0.00% | – |
| Q1 2021 | $19,018,000 | -27.5% | 738 | -35.8% | 0.00% | – |
| Q4 2020 | $26,220,000 | -12.8% | 1,150 | -18.3% | 0.00% | – |
| Q3 2020 | $30,082,000 | +194.6% | 1,407 | +219.8% | 0.00% | – |
| Q2 2020 | $10,212,000 | -66.2% | 440 | -68.9% | 0.00% | – |
| Q1 2020 | $30,189,000 | +104.6% | 1,414 | +124.1% | 0.00% | – |
| Q4 2019 | $14,753,000 | +10.7% | 631 | -0.5% | 0.00% | – |
| Q3 2019 | $13,327,000 | +56.7% | 634 | +52.4% | 0.00% | – |
| Q2 2019 | $8,507,000 | -60.4% | 416 | -45.6% | 0.00% | – |
| Q1 2019 | $21,489,000 | +1316.5% | 765 | +1133.9% | 0.00% | – |
| Q4 2018 | $1,517,000 | -64.2% | 62 | -45.6% | 0.00% | – |
| Q3 2018 | $4,235,000 | +77.5% | 114 | -0.9% | 0.00% | – |
| Q2 2018 | $2,386,000 | +16942.9% | 115 | +11400.0% | 0.00% | – |
| Q1 2018 | $14,000 | -6.7% | 1 | 0.0% | 0.00% | – |
| Q4 2017 | $15,000 | +50.0% | 1 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | +11.1% | 1 | 0.0% | 0.00% | – |
| Q2 2017 | $9,000 | -98.7% | 1 | -98.7% | 0.00% | – |
| Q1 2017 | $694,000 | -75.1% | 78 | -68.9% | 0.00% | – |
| Q4 2016 | $2,786,000 | -40.4% | 251 | -8.7% | 0.00% | – |
| Q3 2016 | $4,672,000 | +34.2% | 275 | +71.9% | 0.00% | – |
| Q2 2016 | $3,482,000 | +43.1% | 160 | +26.0% | 0.00% | – |
| Q1 2016 | $2,433,000 | -79.8% | 127 | -70.5% | 0.00% | – |
| Q4 2015 | $12,052,000 | -11.3% | 430 | -22.9% | 0.00% | – |
| Q3 2015 | $13,593,000 | +149.6% | 558 | +138.5% | 0.00% | – |
| Q2 2015 | $5,445,000 | – | 234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
| Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
| RK Capital | 211,325 | $4,512,000 | 2.03% |
| Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
| Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
| CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
| ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
| Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
| GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |